MedTrace Logo

NOLA (NeuWave Observational Liver Ablation) Registry

NCT04107766 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1254

Last updated 2026-04-17

Study results available
· View outcomes & findings →

Summary

This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.

Conditions

Interventions

DEVICE

Microwave Ablation

Patients who meet the eligibility criteria will undergo microwave ablation (MWA) with the NEUWAVE Microwave Ablation System with or without Ablation Confirmation of at least one soft-tissue liver lesion, in accordance with the study site's standard-of-care (SOC) practices.

Sponsors & Collaborators

  • Ethicon, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-15
Primary Completion
2025-06-18
Completion
2025-06-18
FDA Device
Yes

Countries

  • United States
  • China
  • France
  • Germany
  • Netherlands
  • Singapore
  • South Korea
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04107766 on ClinicalTrials.gov